Benzannelated derivatives, their manufacture and use as...

Details Benzannelated derivatives, their manufacture and use as... Benzannelated derivatives, their manufacture and use as...

2004-10-29

2009-02-24

Andres, Janet L (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S277000, C514S357000, C544S335000, C546S335000

Reexamination Certificate

active

07495001

ABSTRACT:
There are presented compounds of the formulawherein R6and R7isR4and R5or R5and R6together with the carbon atoms to which they are attached, form a ring as defined in the description and X1, X2, Y1to Y4, R1to R13and n are as specified in the description, and to all enantiomers and pharmaceutically acceptable salts and/or esters thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPARδ and/or PPARα agonists.

REFERENCES:
patent: 1 266 888 (2002-12-01), None
patent: WO 97/27858 (1997-08-01), None
patent: WO 02/08188 (2002-01-01), None
patent: WO 02/092084 (2002-11-01), None
patent: WO 03/072100 (2003-09-01), None
patent: WO 03/084916 (2003-10-01), None
patent: WO 03084916 (2003-10-01), None
2003:818386 HCAPLUS, WO 2003084916 A2 Oct. 16, 2003, Filzen et. al.
Anal. Biochem. 257: 112-119.
Belostotskii, Anatoly M., et. al., Tetrahedron Lett (1994), 35(28), 5075-6.
E.J. Corey, et. al., Am. Chem. Soc (1987) 109, 5551-5553.
Guerre-Millo, et. al., J. Biol Chem (2000) 275: 16638-16642.
Lobiner, et. al., Tetrahedron Lett. (1984), 25, 2535-3536.
S.W. McCombie, et. al., Bioorganic & Medicinal Chemistry Ltrs 13 (2003) 567-571.
Oliver, et. al., Proc Nat Acad Sci USA (2001) 98: 5306-11.
P.V. Ramachandran, e.t al., Tetrahedron: Asymmetry (1994) 5, 1061-1074.
Tetrahedron Letters 43 (42), 7617-7619 (2002).
J. Labelled Compounds & Radiopharmaceuticals 43 (7), 683-691 (2000).
P. Keller, Bull. Soc. Fr. (1994) 131, 27-29.
W. Zhi-Liang, et. al., J. Org. Chem. (2003)web publication release Oct. 10, 2003.
Patent Abstracts of Japan, vol. 2003, No. 10, (2003) & JP 2003 171275 A (Sumitomo Pharmaceut Co Ltd), (2003) Abstract.
Patent Abstracts of Japan, vol. 2003, No. 12, (2003) & JP 2003 292439 A (Sumitomo Pharmaceut Co Ltd), (2003) Abstract.

Affiliated with

Also associated with

Rating

Benzannelated derivatives, their manufacture and use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzannelated derivatives, their manufacture and use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzannelated derivatives, their manufacture and use as... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4063024